Results 231 to 240 of about 37,898 (281)

The Prognostic Significance of the Pan-Immune-Inflammation Value in Patients with Heart Failure with Reduced Ejection Fraction. [PDF]

Diagnostics (Basel)
Dervis E, Yakut I, Inan D.
europepmc   +1 more source

Molecular Mechanisms of L-Type Calcium Channel Dysregulation in Heart Failure. [PDF]

Int J Mol Sci
Khalid A, Ahmed AB, Gill R, Shaikh T, Khorsandi J, Kia A.   +5 more
europepmc   +1 more source

Erythrocytosis incidence and thromboembolic risk in heart failure with reduced ejection fraction treated with SGLT2 inhibitors: a nationwide register-based cohort study. [PDF]

Cardiovasc Diabetol
Mohamed AA, Andersen CF, Christensen DM, Riis-Vestergaard LD, Mohammad M, Elmegaard M, Binding C, Torp-Pedersen C, Biering-Sørensen T, Hansen ML, Køber L, Glenthøj A, Jensen J, Andersson C, Schou M, Gislason G.   +15 more
europepmc   +1 more source

Revisiting Transvenous Phrenic Nerve Stimulation in Central Sleep Apnoea and Heart Failure: Emerging Innovations in Clinical Trials Analysis. [PDF]

Card Fail Rev
Bekfani T, Abraham JD, Abraham WT.
europepmc   +1 more source

Early Initiation of Guideline-Directed Medical Therapy Improves Outcomes in Heart Failure with Reduced Ejection Fraction Patients without Significant Risk of Nephrotoxicity. [PDF]

Acta Cardiol Sin
Huang CC, Tzeng BH, Tsai HY, Lee CL, Huang SH, Yeh YT, Hsu JC, Chien CL, Wu YW.   +8 more
europepmc   +1 more source

Impact of Cardiopulmonary Rehabilitation on Patients with Heart Failure Reduced Ejection Fraction and Preserved Ejection Fraction. [PDF]

J Clin Med
Gempel S, Kologie J, Wright T, Decinti D, Cahalin L.   +4 more
europepmc   +1 more source